Building a Pharmacist-Led Furoscix Workflow From Scratch

Craig Beavers details how pharmacists are integrated into the Furoscix workflow at Baptist Health, spanning both inpatient and outpatient sides. Patients identified as inpatient can have the product approved from a medication access standpoint and a prescription secured at discharge, then flow into the heart failure clinic, where teams know the product is on hand. When signs of worsening congestion emerge, pharmacists can call and remind patients to use it, then follow and monitor. In clinic, pharmacists offer it during medication titration so patients have it available if they get into trouble. He also describes using a Zoll HFMS wearable that measures fluid status, with pharmacists following that data to guide diuresis. On discharge planning, Beavers stresses establishing disposition, guideline-directed medication therapy optimization, labs, dry weight, and current congestion status before deciding whether subcutaneous therapy belongs in the plan—then handling prior authorization, product acquisition, and education before the patient leaves. For pharmacists starting from scratch, his advice is to first master access—contracting, distribution, the prior authorization process, and workflow—before approaching cardiology and case management. He suggests educating clinicians and piloting a small group of patients to build the case.